Paragon Private Health has merged with SignatureMD
April 2020 — Paragon Private Health, LLC has merged with SignatureMD.
Paragon Private Health helps create, implement and manage customized concierge medicine programs with private practice physicians to provide enhanced care for patients throughout the USA. It is the only concierge medicine company named to the prestigious Inc. Magazine list of the 5,000 fastest-growing private companies in America in consecutive years 2018 and 2019.
SignatureMD, a portfolio company of Blue Sea Capital, is one of the largest providers of concierge medicine services in the nation. The combined company will serve over 160 physicians across more than 30 states. It will be led by Matt Jacobson, founder and CEO of SignatureMD.
Our role in the transaction
Oaklins’ team in Los Angeles advised Paragon Private Health on this merger.
Talk to the deal team
Kyle Kearney
Oaklins Intrepid
Related deals
Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate
Terhills Resort, a premium resort in Belgium combining luxury and nature located near Hoge Kempen National Park and operated by Center Parcs, has been sold by venture capitalist LRM to TwentyTwo Real Estate, an independent real estate investor and operator. Both the real estate and the operations were included in the transaction, and Center Parcs is staying on board as an operational partner.
Learn moreOEP Danzig BidCo has completed a mandatory tender offer for the shares of Digital Value
OEP Danzig BidCo S.p.A. has completed a mandatory tender offer for the shares of Digital Value S.p.A.
Learn moreBolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company
Bolster Investment Partners has partnered with Royal Taste Company, a leading Dutch custom signature coffee platform offering end-to-end sourcing, blending, roasting, packaging and delivery services. The partnership marks an important next step in Royal Taste Company’s growth trajectory, focused on further geographical expansion, commercial development and selective strategic acquisitions.
Learn more